In this paper, we measure the extent to which a biological marker is a surrogate endpoint for a clinical event by the proportional reduction in the regression coefficient for the treatment indicator due to the inclusion of the marker in the Cox regression model. We estimate this proportion by applyi
✦ LIBER ✦
Counterfactual Links to the Proportion of Treatment Effect Explained by a Surrogate Marker
✍ Scribed by Jeremy M. G. Taylor; Yue Wang; Rodolphe Thiébaut
- Book ID
- 109223342
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 175 KB
- Volume
- 61
- Category
- Article
- ISSN
- 0006-341X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
ESTIMATING THE PROPORTION OF TREATMENT E
✍
D. Y. LIN; T. R. FLEMING; V. DE GRUTTOLA
📂
Article
📅
1997
🏛
John Wiley and Sons
🌐
English
⚖ 362 KB
An Evaluation of a Measure of the Propor
An Evaluation of a Measure of the Proportion of the Treatment Effect Explained by a Surrogate Marker
✍
Paul W Bycott; Jeremy M.G Taylor
📂
Article
📅
1998
🏛
Elsevier Science
🌐
English
⚖ 176 KB
Estimating the proportion of treatment e
✍
Philippe Flandre; Yacine Saidi
📂
Article
📅
1999
🏛
John Wiley and Sons
🌐
English
⚖ 56 KB
Lin, Fleming and DeGruttola (LFD) address the important problem of estimating the proportion of treatment effect (PTE) explained by a surrogate marker. Problems of interpretation of the measure as well as the theoretical basis of its formulation are well explained. This measure has been introduced t
Reduction in coronary events with pravas
✍
J Simes; I Marschner; D Hunt; D Colquhoun; P Glasziou; W Hague; S MacMahon; A Ke
📂
Article
📅
2000
🏛
Elsevier Science
🌐
English
⚖ 125 KB
Effect of GnRH agonist and hCG treatment
✍
María Cerrillo; Alberto Pacheco; Sara Rodríguez; Raúl Gómez; Francisco Delgado;
📂
Article
📅
2011
🏛
Elsevier Science
🌐
English
⚖ 76 KB
IgE-blocking Antibodies may account for
✍
Ljørring, C.; Shamji, M.H.; Würtzen, P.A.; Lund, K.; Frew, A.J.; Durham, S.R.; I
📂
Article
📅
2009
🏛
Elsevier Science
🌐
English
⚖ 43 KB